Opthea Limited (OPT)
USD 3.41
(1.49%)
USD 3.41
(1.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 264.6 Million USD | 68.56% |
| 2023 | 104.49 Million USD | 765.76% |
| 2022 | 12.06 Million USD | 286.43% |
| 2021 | 3.12 Million USD | -7.4% |
| 2020 | 3.37 Million USD | 5.06% |
| 2019 | 3.21 Million USD | -45.02% |
| 2018 | 5.83 Million AUD | 270.87% |
| 2017 | 1.57 Million AUD | 1.94% |
| 2016 | 1.54 Million AUD | -14.35% |
| 2015 | 1.8 Million AUD | -3.36% |
| 2014 | 1.86 Million AUD | 7.75% |
| 2013 | 1.73 Million USD | -30.54% |
| 2012 | 2.49 Million USD | -18.55% |
| 2011 | 3.06 Million USD | 50.06% |
| 2010 | 2.04 Million USD | 26.18% |
| 2009 | 1.61 Million USD | -28.01% |
| 2008 | 2.24 Million USD | -46.98% |
| 2007 | 4.23 Million USD | 233.71% |
| 2006 | 1.26 Million USD | -60.92% |
| 2005 | 3.24 Million USD | 1377.83% |
| 2004 | 219.78 Thousand USD | 1.72% |
| 2003 | 216.07 Thousand USD | 83.26% |
| 2002 | 117.9 Thousand USD | 38.31% |
| 2001 | 85.25 Thousand USD | -34.87% |
| 2000 | 130.89 Thousand USD | 38.51% |
| 1999 | 94.49 Thousand USD | -5.45% |
| 1998 | 99.94 Thousand USD | -20.31% |
| 1997 | 125.42 Thousand USD | 66.8% |
| 1996 | 75.19 Thousand USD | 53.14% |
| 1995 | 49.09 Thousand USD | 109.76% |
| 1994 | 23.4 Thousand USD | 63.3% |
| 1993 | 14.33 Thousand USD | -50.47% |
| 1992 | 28.94 Thousand USD | 29.51% |
| 1991 | 22.34 Thousand USD | 11.53% |
| 1990 | 20.03 Thousand USD | -24.07% |
| 1989 | 26.38 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 264.6 Million USD | 0.0% |
| 2024 Q2 | 213.41 Million USD | 0.0% |
| 2024 FY | 264.6 Million USD | 153.22% |
| 2023 FY | 104.49 Million USD | 765.76% |
| 2023 Q4 | 104.49 Million USD | 0.0% |
| 2023 Q2 | 97.54 Million USD | 0.0% |
| 2022 Q2 | 8.94 Million USD | 0.0% |
| 2022 FY | 12.06 Million USD | 286.43% |
| 2022 Q4 | 12.06 Million USD | 0.0% |
| 2021 Q2 | 12.01 Million USD | 0.0% |
| 2021 FY | 3.12 Million USD | -7.4% |
| 2021 Q4 | 3.12 Million USD | 0.0% |
| 2020 FY | 3.37 Million USD | 5.06% |
| 2020 Q4 | 3.37 Million USD | 0.0% |
| 2020 Q2 | 4.67 Million USD | 0.0% |
| 2019 Q2 | 6.51 Million USD | 0.0% |
| 2019 FY | 3.21 Million USD | -45.02% |
| 2019 Q4 | 3.21 Million USD | 0.0% |
| 2018 FY | 5.83 Million AUD | 270.87% |
| 2018 Q4 | 5.83 Million AUD | 0.0% |
| 2018 Q2 | 3.68 Million USD | 0.0% |
| 2017 Q2 | 1.55 Million USD | 0.0% |
| 2017 Q4 | 1.57 Million AUD | 0.0% |
| 2017 FY | 1.57 Million AUD | 1.94% |
| 2016 Q4 | 1.54 Million AUD | 0.0% |
| 2016 Q2 | 797.61 Thousand USD | 0.0% |
| 2016 FY | 1.54 Million AUD | -14.35% |
| 2015 Q2 | 1.59 Million USD | 0.0% |
| 2015 FY | 1.8 Million AUD | -3.36% |
| 2015 Q4 | 1.8 Million AUD | 0.0% |
| 2014 Q4 | 1.86 Million AUD | 0.0% |
| 2014 Q2 | 1.72 Million USD | 0.0% |
| 2014 FY | 1.86 Million AUD | 7.75% |
| 2013 Q2 | 1.4 Million USD | 0.0% |
| 2013 FY | 1.73 Million USD | -30.54% |
| 2013 Q4 | 1.73 Million USD | -9.35% |
| 2013 Q3 | 1.91 Million USD | 35.96% |
| 2013 Q1 | 1.4 Million USD | -43.65% |
| 2012 FY | 2.49 Million USD | -18.55% |
| 2012 Q4 | 2.49 Million USD | 0.0% |
| 2011 Q4 | 3.06 Million USD | 0.0% |
| 2011 FY | 3.06 Million USD | 50.06% |
| 2010 Q4 | 2.04 Million USD | 0.0% |
| 2010 FY | 2.04 Million USD | 26.18% |
| 2009 FY | 1.61 Million USD | -28.01% |
| 2009 Q4 | 1.61 Million USD | 0.0% |
| 2008 FY | 2.24 Million USD | -46.98% |
| 2008 Q4 | 2.24 Million USD | 0.0% |
| 2007 FY | 4.23 Million USD | 233.71% |
| 2007 Q4 | 4.23 Million USD | 0.0% |
| 2006 Q4 | 1.26 Million USD | 0.0% |
| 2006 FY | 1.26 Million USD | -60.92% |
| 2005 Q4 | 3.24 Million USD | 0.0% |
| 2005 FY | 3.24 Million USD | 1377.83% |
| 2004 Q4 | 219.78 Thousand USD | 0.0% |
| 2004 FY | 219.78 Thousand USD | 1.72% |
| 2003 FY | 216.07 Thousand USD | 83.26% |
| 2003 Q4 | 216.07 Thousand USD | 0.0% |
| 2002 FY | 117.9 Thousand USD | 38.31% |
| 2002 Q4 | 118.03 Thousand USD | 0.0% |
| 2001 Q4 | 85.27 Thousand USD | 0.0% |
| 2001 FY | 85.25 Thousand USD | -34.87% |
| 2000 FY | 130.89 Thousand USD | 38.51% |
| 2000 Q4 | 130.89 Thousand USD | 0.0% |
| 1999 FY | 94.49 Thousand USD | -5.45% |
| 1999 Q4 | 63.08 Thousand USD | 0.0% |
| 1998 FY | 99.94 Thousand USD | -20.31% |
| 1997 Q4 | 94.51 Thousand USD | 0.0% |
| 1997 FY | 125.42 Thousand USD | 66.8% |
| 1996 FY | 75.19 Thousand USD | 53.14% |
| 1995 FY | 49.09 Thousand USD | 109.76% |
| 1994 FY | 23.4 Thousand USD | 63.3% |
| 1993 FY | 14.33 Thousand USD | -50.47% |
| 1992 FY | 28.94 Thousand USD | 29.51% |
| 1991 FY | 22.34 Thousand USD | 11.53% |
| 1990 FY | 20.03 Thousand USD | -24.07% |
| 1989 FY | 26.38 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | 21.197% |
| Alkermes plc | 933.53 Million USD | 71.656% |
| Agenus Inc. | 462.29 Million USD | 42.764% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.467% |
| Aptorum Group Limited | 5.25 Million USD | -4933.564% |
| Ardelyx, Inc. | 130.76 Million USD | -102.352% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 44.689% |
| Bicycle Therapeutics plc | 224.41 Million USD | -17.909% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -103.211% |
| ChromaDex Corporation | 26.5 Million USD | -898.194% |
| Chimerix, Inc. | 19.74 Million USD | -1240.093% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -652.197% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -264.63% |
| CRISPR Therapeutics AG | 346.76 Million USD | 23.695% |
| Precision BioSciences, Inc. | 140.92 Million USD | -87.767% |
| Dyadic International, Inc. | 2.34 Million USD | -11204.603% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1527.014% |
| Fortress Biotech, Inc. | 165.93 Million USD | -59.457% |
| Lantern Pharma Inc. | 2.73 Million USD | -9558.102% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -270.175% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7398.496% |
| Incyte Corporation | 1.59 Billion USD | 83.382% |
| IO Biotech, Inc. | 17.55 Million USD | -1407.184% |
| Jaguar Health, Inc. | 45.86 Million USD | -476.901% |
| Novavax, Inc. | 2.57 Billion USD | 89.713% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -633.821% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -102.439% |
| ContextLogic Inc. | 206 Million USD | -28.447% |
| MiMedx Group, Inc. | 96.33 Million USD | -174.682% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -451.0% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7398.151% |
| NextCure, Inc. | 14.99 Million USD | -1664.361% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6446.296% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -3862.877% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -466.125% |
| Vaxcyte, Inc. | 167.44 Million USD | -58.019% |
| PDS Biotechnology Corporation | 33.25 Million USD | -695.575% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -12.494% |
| Pharming Group N.V. | 244.07 Million USD | -8.411% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2119.437% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -107.058% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3904.694% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3904.694% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -220.99% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -3883.16% |
| Acelyrin, Inc. | 86.35 Million USD | -206.418% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -20265.836% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1740.193% |
| Summit Therapeutics Inc. | 125.25 Million USD | -111.247% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2691.447% |
| Senti Biosciences, Inc. | 52.57 Million USD | -403.322% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -284.724% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -74.64% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -13427.673% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -19711.952% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -16.651% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2724.824% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -16.336% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 46.492% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2324.421% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -861.802% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2085.939% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 45.623% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7009.53% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -599.781% |
| MEI Pharma, Inc. | 8.35 Million USD | -3066.981% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -811.947% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 23.873% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -81.397% |
| Fortress Biotech, Inc. | 165.93 Million USD | -59.457% |
| Precigen, Inc. | 41.64 Million USD | -535.389% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -429.945% |
| AlloVir, Inc. | 45.01 Million USD | -487.807% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -103.013% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -92.018% |
| ImmuCell Corporation | 18.81 Million USD | -1306.33% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -837.438% |
| Onconetix, Inc. | 23.18 Million USD | -1041.463% |
| PureTech Health plc | 125.58 Million USD | -110.698% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2856.439% |
| Elevation Oncology, Inc. | 34.28 Million USD | -671.837% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -10722.139% |
| Seer, Inc. | 39.36 Million USD | -572.174% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -327.922% |
| Innoviva, Inc. | 568.55 Million USD | 53.46% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -871.798% |
| ESSA Pharma Inc. | 3.49 Million USD | -7470.699% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3733.649% |
| GT Biopharma, Inc. | 6.63 Million USD | -3889.165% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -0.08% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | 2.823% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -214.904% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2607.196% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -873.909% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8102.725% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -258.699% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1573.77% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2296.819% |
| Soligenix, Inc. | 7.27 Million USD | -3537.179% |
| Century Therapeutics, Inc. | 175.94 Million USD | -50.392% |
| Kura Oncology, Inc. | 51.66 Million USD | -412.178% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -118.17% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6302.16% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -3900.712% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -4.752% |
| Autolus Therapeutics plc | 263.9 Million USD | -0.263% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2424.34% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -197.77% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -464.194% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 25.012% |
| GRI Bio, Inc. | 2.69 Million USD | -9710.949% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -32583.571% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -751.054% |
| IGM Biosciences, Inc. | 220.17 Million USD | -20.177% |
| INmune Bio, Inc. | 18.86 Million USD | -1302.827% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -3.167% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -893.181% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9633.693% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -7966.458% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -352.658% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -175.171% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | 0.051% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 67.85% |
| Verastem, Inc. | 71.18 Million USD | -271.709% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -438.07% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -585.886% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -440.753% |
| Histogen Inc. | 5.69 Million USD | -4544.572% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -5933.405% |
| Surrozen, Inc. | 8.14 Million USD | -3148.635% |
| Organovo Holdings, Inc. | 2.74 Million USD | -9528.868% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -84206.053% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -370.57% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1502.479% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -417.78% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -31900.156% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -108.8% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2346.933% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -75.362% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10048.304% |
| Apollomics, Inc. | 14.15 Million USD | -1769.577% |
| Amarin Corporation plc | 279.58 Million USD | 5.36% |
| Mesoblast Limited | 188.79 Million USD | -40.15% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1770.238% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -46.36% |
| Synaptogenix, Inc. | 5.52 Million USD | -4685.293% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -3880.164% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -55.549% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2992.151% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -14956.467% |
| Exelixis, Inc. | 678.44 Million USD | 60.999% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1009.812% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -61.297% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 55.47% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2377.493% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -16197.036% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -579.737% |
| Gritstone bio, Inc. | 125.91 Million USD | -110.136% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1702.952% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5099.856% |
| Avid Bioservices, Inc. | 275.66 Million USD | 4.015% |
| Insmed Incorporated | 1.66 Billion USD | 84.077% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3339.049% |
| MediWound Ltd. | 27.18 Million USD | -873.264% |
| OmniAb, Inc. | 87.4 Million USD | -202.747% |
| Alector, Inc. | 487.66 Million USD | 45.742% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 34.416% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1336.099% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -589.551% |
| Zai Lab Limited | 240.17 Million USD | -10.169% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 58.004% |
| Aura Biosciences, Inc. | 29.22 Million USD | -805.332% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -178.302% |
| Immunic, Inc. | 25.36 Million USD | -943.051% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -282.173% |
| Veracyte, Inc. | 93.71 Million USD | -182.335% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10012.127% |
| FibroGen, Inc. | 585.72 Million USD | 54.825% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1422.184% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -40416.156% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4578.689% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.544% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3127.632% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -214.919% |
| TG Therapeutics, Inc. | 169.08 Million USD | -56.49% |
| Galecto, Inc. | 5.89 Million USD | -4387.81% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3094.125% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.895% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -818.053% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -1996.516% |
| XBiotech Inc. | 8.39 Million USD | -3051.141% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1702.952% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -397.558% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 27.128% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -884.233% |
| Theravance Biopharma, Inc. | 169 Million USD | -56.565% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 78.233% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 47.125% |
| Vaxxinity, Inc. | 30.94 Million USD | -755.097% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 72.791% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4287.276% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 64.494% |
| NexImmune, Inc. | 5.08 Million USD | -5104.351% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -71145.441% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -8505.345% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.277% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5033.872% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3449.583% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -906.318% |
| Ainos, Inc. | 7.39 Million USD | -3478.487% |
| Pluri Inc. | 34.11 Million USD | -675.684% |
| Prothena Corporation plc | 135.01 Million USD | -95.976% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -8.843% |
| Celularity Inc. | 102.92 Million USD | -157.072% |
| Rallybio Corporation | 9.43 Million USD | -2704.168% |
| Cue Biopharma, Inc. | 24.44 Million USD | -982.435% |
| MeiraGTx Holdings plc | 319.99 Million USD | 17.31% |
| Omeros Corporation | 403.25 Million USD | 34.383% |
| Humacyte, Inc. | 114.67 Million USD | -130.736% |
| Immunocore Holdings plc | 228.15 Million USD | -15.973% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5327.719% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -244.802% |
| Blueprint Medicines Corporation | 918.64 Million USD | 71.196% |
| CalciMedica, Inc. | 4.02 Million USD | -6469.049% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1416.166% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -71.66% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -208.332% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 4.749% |
| Pulmatrix, Inc. | 15.96 Million USD | -1557.591% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1577.558% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -975.353% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -5.5% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -421.012% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 78.144% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -732.525% |
| Nutriband Inc. | 1.07 Million USD | -24424.667% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2388.491% |
| Vor Biopharma Inc. | 59.1 Million USD | -347.688% |
| Roivant Sciences Ltd. | 773.95 Million USD | 65.812% |
| Evogene Ltd. | 17.99 Million USD | -1370.824% |
| ProKidney Corp. | 29.21 Million USD | -805.673% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -267.609% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -37433.003% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 85.992% |
| CorMedix Inc. | 11.91 Million USD | -2120.27% |
| BioLineRx Ltd. | 50.7 Million USD | -421.875% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -77.039% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -199.184% |
| Atai Life Sciences N.V. | 49.16 Million USD | -438.223% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -749.379% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1373.117% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -112.299% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4579.896% |
| MediciNova, Inc. | 3.89 Million USD | -6699.375% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1347.57% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -17490.352% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7417.336% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 33.393% |
| Biomea Fusion, Inc. | 30.69 Million USD | -762.174% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 90.278% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1557.695% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -748.054% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -350.892% |
| Absci Corporation | 58.3 Million USD | -353.83% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1289.129% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -725.28% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -258.587% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -202.46% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -683.54% |
| Allakos Inc. | 74.79 Million USD | -253.778% |
| Imunon, Inc. | 8.53 Million USD | -3001.853% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1075.953% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -130.465% |
| BioAtla, Inc. | 48.98 Million USD | -440.157% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2377.493% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -9421.457% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -102.598% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1761.423% |
| XOMA Corporation | 145.58 Million USD | -81.757% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -685.983% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -284.824% |
| aTyr Pharma, Inc. | 31.59 Million USD | -737.425% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -327.998% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -488.461% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -446.674% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9119.557% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3143.451% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5672.279% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1392.13% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 83.958% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -65410.287% |
| UroGen Pharma Ltd. | 243.52 Million USD | -8.656% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 17.592% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -9481.595% |
| Orgenesis Inc. | 35.53 Million USD | -644.622% |
| Entera Bio Ltd. | 1.37 Million USD | -19087.911% |
| GH Research PLC | 6.7 Million USD | -3848.684% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3791.195% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1305.51% |
| Xencor, Inc. | 283.55 Million USD | 6.686% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -8762.361% |
| Replimune Group, Inc. | 113.21 Million USD | -133.718% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -6942.653% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -155.579% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -65410.287% |
| Portage Biotech Inc. | 4.45 Million USD | -5846.096% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -17490.352% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1047.945% |
| OncoCyte Corporation | 49.29 Million USD | -436.738% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6296.272% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -33079.511% |
| Purple Biotech Ltd. | 10 Million USD | -2544.691% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4473.13% |
| scPharmaceuticals Inc. | 57.26 Million USD | -362.097% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2035.945% |
| HilleVax, Inc. | 78.9 Million USD | -235.325% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5139.63% |
| Tharimmune, Inc. | 1.81 Million USD | -14478.214% |
| Genprex, Inc. | 3.25 Million USD | -8031.05% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -875.704% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -4953.501% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -128347.229% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -73698.011% |
| OKYO Pharma Limited | 7.42 Million USD | -3465.649% |
| Savara Inc. | 37.19 Million USD | -611.447% |
| Curis, Inc. | 57.61 Million USD | -359.282% |
| Daré Bioscience, Inc. | 26.32 Million USD | -904.948% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -575.007% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -18224.189% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1170.961% |
| BeiGene, Ltd. | 2.23 Billion USD | 88.154% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1142.855% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -0.84% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1143.778% |
| Erasca, Inc. | 78.61 Million USD | -236.596% |
| bluebird bio, Inc. | 424.62 Million USD | 37.686% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -40281.608% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 86.0% |
| DBV Technologies S.A. | 42.8 Million USD | -518.227% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -40281.608% |
| Moderna, Inc. | 4.57 Billion USD | 94.213% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3682.72% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -15878.339% |
| Molecular Templates, Inc. | 31.17 Million USD | -748.87% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1450.095% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 55.008% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -112.523% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -864.396% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -625.81% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -375.602% |
| MacroGenics, Inc. | 154.2 Million USD | -71.588% |
| RenovoRx, Inc. | 4.46 Million USD | -5824.794% |
| Adicet Bio, Inc. | 37.12 Million USD | -612.827% |
| Prime Medicine, Inc. | 60.78 Million USD | -335.343% |
| Aditxt, Inc. | 28.53 Million USD | -827.399% |
| Adagene Inc. | 45.16 Million USD | -485.798% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -146330.453% |
| Quantum-Si incorporated | 26.63 Million USD | -893.584% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 62.068% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -8597.015% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -130.166% |
| SciSparc Ltd. | 1.59 Million USD | -16489.423% |
| Vericel Corporation | 127.7 Million USD | -107.197% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4654.831% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -209.99% |
| Generation Bio Co. | 171.63 Million USD | -54.17% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2190.92% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -532.548% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -4.71% |
| Invivyd, Inc. | 51.71 Million USD | -411.673% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -187.682% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -3967.503% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -250.484% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -25815.895% |
| 2seventy bio, Inc. | 310.12 Million USD | 14.679% |
| ADMA Biologics, Inc. | 193.97 Million USD | -36.409% |
| Clene Inc. | 38.95 Million USD | -579.318% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -632.301% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -2.967% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7417.336% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -39.071% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2072.485% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -33.42% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2069.788% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -449.981% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -400.75% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 28.458% |
| Evaxion Biotech A/S | 17.61 Million USD | -1401.925% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -64.421% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -72.732% |
| Trevena, Inc. | 48.26 Million USD | -448.26% |
| Surrozen, Inc. | 8.14 Million USD | -3148.635% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1125.29% |
| Cingulate Inc. | 10.36 Million USD | -2453.853% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -9521.865% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -609.539% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7277.661% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1912.177% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 16.582% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -964.837% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7229.659% |
| Kronos Bio, Inc. | 54.2 Million USD | -388.185% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -462.467% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1062.585% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1218.326% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1066.855% |
| ImmunityBio, Inc. | 1.09 Billion USD | 75.733% |
| Korro Bio, Inc. | 51.75 Million USD | -411.287% |
| Kineta, Inc. | 7.22 Million USD | -3563.823% |
| BioVie Inc. | 9.7 Million USD | -2627.25% |
| Codexis, Inc. | 49.94 Million USD | -429.775% |
| Celularity Inc. | 102.92 Million USD | -157.072% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -174.919% |
| Celcuity Inc. | 51.45 Million USD | -414.287% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -76552.923% |
| Cibus, Inc. | 206.11 Million USD | -28.374% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -522.958% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -904.599% |
| IN8bio, Inc. | 8.77 Million USD | -2916.431% |
| Kodiak Sciences Inc. | 213.59 Million USD | -23.882% |
| Annexon, Inc. | 47.11 Million USD | -461.572% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -195.509% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -174.562% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1832.948% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.836% |
| Eyenovia, Inc. | 19.78 Million USD | -1237.702% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -49.42% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3344.881% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -997.976% |
| Arcellx, Inc. | 339.75 Million USD | 22.119% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2123.914% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -7.763% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2666.928% |
| Moolec Science SA | 13.94 Million USD | -1797.415% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -513.184% |
| Geron Corporation | 146.12 Million USD | -81.076% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -423.631% |
| Royalty Pharma plc | 6.29 Billion USD | 95.798% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -565.229% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -89776.325% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -10654.917% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -39.885% |
| Humacyte, Inc. | 114.67 Million USD | -130.736% |
| Structure Therapeutics Inc. | 29.05 Million USD | -810.816% |
| 89bio, Inc. | 59.96 Million USD | -341.274% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -899.892% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -22023.854% |
| Genelux Corporation | 8.42 Million USD | -3042.533% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3759.412% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -94.104% |
| Notable Labs, Ltd. | 4.42 Million USD | -5876.989% |
| Liquidia Corporation | 73.13 Million USD | -261.784% |
| Mustang Bio, Inc. | 17.61 Million USD | -1401.795% |
| Immunovant, Inc. | 48.95 Million USD | -440.499% |
| Quantum-Si incorporated | 26.63 Million USD | -893.584% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -589.371% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -8427.273% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -258.242% |
| Acasti Pharma Inc. | 11.55 Million USD | -2189.533% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1070.402% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9633.693% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -617.524% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -19315.405% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4240.572% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -965.437% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1041.31% |
| PepGen Inc. | 34.63 Million USD | -664.059% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2078.864% |
| United Therapeutics Corporation | 1.18 Billion USD | 77.618% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3688.678% |
| Solid Biosciences Inc. | 38.45 Million USD | -588.027% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2992.151% |
| Immuneering Corporation | 12 Million USD | -2103.477% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -84206.053% |
| Silo Pharma, Inc. | 1.56 Million USD | -16761.426% |
| Belite Bio, Inc | 4.21 Million USD | -6183.574% |
| XOMA Corporation | 145.58 Million USD | -81.757% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -10797.912% |
| Bionomics Limited | 10.15 Million USD | -2504.671% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1131.219% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1054.809% |
| uniQure N.V. | 624.01 Million USD | 57.597% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1764.046% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -146330.453% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -55.48% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7117.711% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -101442.039% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -3821.762% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3344.881% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1422.184% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2403.797% |
| Altimmune, Inc. | 16.54 Million USD | -1499.669% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 57.164% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1054.809% |
| Compugen Ltd. | 55.77 Million USD | -374.408% |
| Peak Bio, Inc. | 20.75 Million USD | -1174.98% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -139.538% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5232.553% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -67.636% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -251.985% |
| Zura Bio Limited | 21.29 Million USD | -1142.726% |
| PolyPid Ltd. | 17.46 Million USD | -1414.777% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -135.412% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -251.985% |
| Instil Bio, Inc. | 99.8 Million USD | -165.129% |
| argenx SE | 444.95 Million USD | 40.532% |
| Immunome, Inc. | 28.65 Million USD | -823.307% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3073.819% |
| Verona Pharma plc | 58.84 Million USD | -349.689% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1728.241% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1680.748% |
| CervoMed Inc. | 2.59 Million USD | -10093.647% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5328.832% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -1977.586% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2411.64% |
| Moolec Science SA | 13.94 Million USD | -1797.415% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -11190.84% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -375.942% |
| AnaptysBio, Inc. | 364.28 Million USD | 27.364% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2113.126% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -1986.103% |
| NeurAxis, Inc. | 1.91 Million USD | -13733.633% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -579.72% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1884.559% |
| Achilles Therapeutics plc | 19.08 Million USD | -1286.291% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1728.241% |
| 180 Life Sciences Corp. | 5.38 Million USD | -4811.658% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1021.763% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1062.585% |
| Nutriband Inc. | 1.07 Million USD | -24424.667% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -764.767% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1723.453% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 34.06% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -714.835% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1927.737% |
| Palisade Bio, Inc. | 2.73 Million USD | -9560.507% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -4937.146% |
| Beam Therapeutics Inc. | 478.38 Million USD | 44.689% |
| Neurogene Inc. | 36.54 Million USD | -623.963% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 33.509% |
| AEON Biopharma, Inc. | 159.88 Million USD | -65.491% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -455.302% |
| Sesen Bio, Inc. | 30.98 Million USD | -753.993% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -919.226% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3380.581% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -35.181% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -37.772% |
| Athira Pharma, Inc. | 30.05 Million USD | -780.332% |
| Vaccinex, Inc. | 5.94 Million USD | -4353.068% |
| HCW Biologics Inc. | 15.05 Million USD | -1657.921% |
| XOMA Corporation | 145.58 Million USD | -81.757% |
| Nektar Therapeutics | 267.04 Million USD | 0.915% |
| Arvinas, Inc. | 644.6 Million USD | 58.951% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1392.13% |
| Merus N.V. | 102.15 Million USD | -159.03% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -80.8% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -178.176% |
| Rezolute, Inc. | 11.73 Million USD | -2154.997% |
| Clene Inc. | 38.95 Million USD | -579.318% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9192.799% |
| BeyondSpring Inc. | 48.26 Million USD | -448.181% |
| Synlogic, Inc. | 32.89 Million USD | -704.381% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1710.725% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -16093.47% |
| Peak Bio, Inc. | 20.75 Million USD | -1174.98% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -316.964% |
| Krystal Biotech, Inc. | 39.71 Million USD | -566.267% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 29.748% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -165.747% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -61047.537% |
| MannKind Corporation | 721.36 Million USD | 63.319% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1084.693% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -12584.626% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -157.921% |
| Gossamer Bio, Inc. | 249.14 Million USD | -6.203% |
| CohBar, Inc. | 1.03 Million USD | -25499.029% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2375.454% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1289.129% |
| Legend Biotech Corporation | 589.93 Million USD | 55.147% |
| Mural Oncology plc | 37.92 Million USD | -597.641% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -99.494% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -11427.8% |
| Disc Medicine, Inc. | 22.87 Million USD | -1056.727% |
| Champions Oncology, Inc. | 28.03 Million USD | -843.825% |
| REGENXBIO Inc. | 262.22 Million USD | -0.905% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -7776.558% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2011.068% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1869.987% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1147.825% |
| Vaxart, Inc. | 34.02 Million USD | -677.667% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1197.748% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -827.388% |
| Cellectis S.A. | 249.57 Million USD | -6.021% |
| Longeveron Inc. | 5.33 Million USD | -4857.866% |
| Repare Therapeutics Inc. | 41.81 Million USD | -532.73% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 88.999% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -338.314% |
| Revolution Medicines, Inc. | 262.39 Million USD | -0.84% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -12458.201% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -2967.485% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2142.194% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1784.222% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -12201.315% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.862% |
| Denali Therapeutics Inc. | 122.96 Million USD | -115.188% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4654.831% |
| Veru Inc. | 32.81 Million USD | -706.399% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3752.108% |
| Cingulate Inc. | 10.36 Million USD | -2453.853% |
| Passage Bio, Inc. | 39.26 Million USD | -573.937% |
| Context Therapeutics Inc. | 4.19 Million USD | -6212.483% |
| Exicure, Inc. | 8.54 Million USD | -2995.114% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -796.71% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2423.377% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1100.496% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -62.346% |
| Nuvalent, Inc. | 31.82 Million USD | -731.478% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4059.334% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -319.855% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1370.007% |
| OmniAb, Inc. | 87.4 Million USD | -202.747% |
| Anew Medical, Inc. | 8.24 Million USD | -3110.48% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -591.062% |
| Lipocine Inc. | 2.63 Million USD | -9954.658% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -907.161% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -558.016% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -893.181% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -207.126% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -4799.117% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -219.771% |
| Ocugen, Inc. | 23.98 Million USD | -1003.287% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -470.175% |
| Q32 Bio Inc. | 233.12 Million USD | -13.5% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2818.611% |
| Alumis Inc. Common Stock | 53.5 Million USD | -394.563% |
| Equillium, Inc. | 27.95 Million USD | -846.458% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -28.079% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4602.631% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4214.408% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -68.187% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -281.089% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2552.857% |
| Dominari Holdings Inc. | 4.63 Million USD | -5608.766% |
| Edesa Biotech, Inc. | 1.84 Million USD | -14267.722% |
| vTv Therapeutics Inc. | 29.56 Million USD | -794.921% |
| Bio-Techne Corporation | 744.34 Million USD | 64.452% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -109.836% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 23.183% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -552.129% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -813.773% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -186.489% |
| Nkarta, Inc. | 105.6 Million USD | -150.569% |
| BioCardia, Inc. | 4.59 Million USD | -5664.734% |
| Iterum Therapeutics plc | 32.66 Million USD | -710.12% |